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The transition to university marks a point where young people may be open to changing health 
behaviours such as smoking, exercise, diet and alcohol intake. This study aimed to estimate the cost-
effectiveness of an updated online health behaviour intervention for new university students in the UK – 
“U@Uni2”, compared with both a control (measurement only) scenario and with the original 
intervention (“U@Uni1”). The economic analysis, based on a randomized controlled trial, comprised a 
detailed costing analysis, a within-trial cost-effectiveness analysis and long-term economic modelling. 
Cost-effectiveness of the U@Uni2 trial was estimated using 6-month data on costs and health-related 
quality of life. An individual patient simulation model was adapted for long-term economic analysis of 
U@Uni2. Probabilistic sensitivity analysis and value of information analysis accounted for uncertainty 
in model inputs and identified key parameters. The U@Uni2 intervention costs £45.97 per person for full 
implementation, £10.43 per person for roll-out in a different institution and £3.03 per person for roll-out 
over five years. The U@Uni2 trial was not cost-effective because marginally fewer quality-adjusted life 
years (QALYs) were obtained in the intervention arm than the control. However, modelled over a 
lifetime, U@Uni2 is estimated to produce more QALYs than control but fewer than U@Uni1, primarily 
due to the effect of the interventions on smoking. Roll-out of U@Uni2 is highly likely to be more cost-
effective than doing nothing (ICER = £536 per QALY, 86% probability cost-effective). Decision 
uncertainty occurs primarily around the effectiveness of the U@Uni2 intervention and is worth up to 
£3.24 m. The U@Uni2 intervention is highly likely to be cost-effective to roll-out when compared with 
doing nothing. The results suggest that preventing uptake of smoking is the key driver of QALY gain 
and should be the primary target of such interventions.  
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INTRODUCTION 
 
The National Health Service (NHS) spends billions of 
pounds per year treating the  burden  of  disease  caused 
by unhealthy lifestyle choices such as smoking, excessive 
drinking, lack  of exercise and poor diet (The King's Fund, 
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2014). Many of these behaviours are adopted early in 
adulthood, and ultimately result in an increased risk of 
disease and mortality, and a reduction in health-related 
quality-of-life. The transition between school and 
university is a point when individuals are likely to change 
existing health behaviours and establish new habits 
(Friedman et al., 2008; Plotnikoff et al., 2015). U@Uni is 
an online intervention based upon the psychological 
theories of self-affirmation, planned behaviour and 
implementation intentions (Ajzen, 2005; Gollwitzer and 
Sheeran, 2006; Harris and Epton, 2009), which targets 
four health behaviours: smoking, drinking alcohol, eating 
fruit and vegetables, and physical activity in new 
university students. A 2012 randomized clinical trial 
(RCT) of a first variant U@Uni1 and a full economic 
analysis of U@Uni1 versus „measurement only‟ control 
concluded that although the effect of the intervention on 
health behaviours was small, rolling out the intervention 
to other universities would be cost-effective (Epton et al., 
2014; Kruger et al., 2014). 
The U@Uni1 trial suffered from low levels of 
recruitment and technological problems, resulting in poor 
engagement with the intervention. An updated version of 
the intervention (U@Uni2) was designed using the 
LifeGuide intervention software developed by 
Southampton University (Yang et al., 2009), which helped 
to minimize technical problems. The pre-intervention 
baseline questionnaire was also shortened. The U@Uni2 
intervention was compared with the control in an RCT of 
2,623 undergraduates beginning their studies in 2013 at 
the University of Sheffield, United Kingdom. Results from 
the trial are available elsewhere (Cameron et al., 2015). 
This economic evaluation aims to estimate the short-
term (6-month) and long-term (lifetime) cost-effectiveness 
of U@Uni2, when compared with both the „measurement 
only‟ control condition and also with the U@Uni1 
intervention. The perspective of the study is that of the UK 
Department of Health. 
 
 
METHODS 
 
The economic evaluation took the same format as U@Uni1 (Kruger 
et al., 2014), with three components: a costing analysis; a within-
trial analysis; and an economic modelling analysis to estimate long-
term cost-effectiveness of the U@Uni2 intervention, when compared 
with either the control condition or with the U@Uni1 intervention. 
The methods are summarized here; detailed methods are available 
in the online supplementary appendix. 
 
 
Costing analysis 
 
The costs of U@Uni2 were estimated using a modified version of 
theU@Uni1   staff   costs  questionnaire  (Kruger  et  al.,  2014  and  
 
 
 
 
Additional file 1). Staff from the Department of Psychology were 
asked to estimate the number of hours they had spent developing, 
updating and implementing the U@Uni2 intervention in addition to 
any non-staff costs incurred. The full economic cost of all staff time 
including overheads, national insurance and pension costs was 
estimated using the University of Sheffield‟s University Research 
Management System. Costs were calculated at 2013 values. Three 
different scenarios were costed for long-term modelling. The cost of 
full implementation of a U@Uni2 style intervention including 
development costs, the cost for roll-out of the existing U@Uni2 
intervention to another university, and the cost of rolling out the 
intervention assuming it could be used for five years with minimal 
updating (five-year costs). Roll-out costs were estimated in a similar 
manner by including the cost of developing local elements from 
U@Uni1 in addition to a subset of costs from U@Uni2. Five-year 
costs were based upon roll-out costs but were divided into an 
annuitized set-up cost and an annual maintenance cost. The long-
term economic modelling allows three-way comparison of control, 
U@Uni1 and U@Uni2 interventions. To allow direct comparison, all 
costs from U@Uni1 were inflated to 2013 values using the 
consumer price index from the Office of National Statistics (ONS) 
(Office for National Statistics, 2014).  
 
 
Within-trial cost-effectiveness analysis (short-term 6-month 
time horizon) 
 
A within-trial analysis was performed by balancing the gain in 
QALYs accrued during the trial against the cost of healthcare and 
the costs of full implementation of the U@Uni2 intervention. 
Healthcare costs were calculated from questionnaire data that 
asked about healthcare utilisation during the trial period (Cameron 
et al., 2015). NHS Reference Costs 2012-13 (Department of Health, 
2013) and the Unit Costs of Health and Social Care 2013 (Personal 
Social Service Research Unit, 2013) were used to assign unit costs 
to each healthcare source used. Data on health-related quality of 
life was collected at baseline, one month and six month time-points, 
and weighted using preference based EQ-5D values (Dolan et al., 
1995). Missing data for costs and health-related quality of life was 
imputed using multiple imputation by chained equations (White et 
al., 2011). Baseline characteristics of the individuals who took part 
in the trial are presented in Appendix Table 1. Ordinary least 
squares (OLS) regression models were generated to estimate total 
costs and QALYs using personal characteristics as covariates. 
 
 
Long-term economic modelling (lifetime time horizon) 
 
Long-term cost-effectiveness of the U@Uni2 intervention was 
assessed using an adaptation of the U@Uni1 economic model 
(Kruger et al., 2014). The model is a population based individual 
patient-level simulation that models individuals selected from 
baseline data collected in the U@Uni2 trial. Their age, gender, 
portions of fruit/vegetables consumed daily, units of alcohol 
consumed weekly, minutes of physical activity undertaken weekly 
and smoking status influence their probability of dying and their 
estimated utility during each year of their life. The same individuals 
were simulated in control conditions and with the U@Uni1 and 
U@Uni2 interventions. Life years, QALYs and costs were 
discounted annually at 1.5% as recommended by NICE for public 
health economic evaluations (National Institute for Health and 
Clinical  Excellence,  2012). Incremental analysis was carried out to  
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compare each of the interventions with the control condition and 
with each other. 
 
 
Uncertainty 
 
Probabilistic sensitivity analysis (PSA) was carried out to estimate 
the probability of the interventions being cost-effective at different 
willingness to pay thresholds. 30,000 model runs were performed, 
each simulating 1000 random individuals. Expected value of perfect 
information (EVPI) and partial expected value of perfect information 
(EVPPI) were carried out, using the Sheffield Accelerated Value of 
Information (SAVI) online tool (Strong et al., 2014), to determine the 
value of further research into parameter estimation. 
A series of structural sensitivity analyses were carried out to test 
certain model assumptions. The sensitivity of the results of the 
duration of intervention effect was tested by fixing the mean at 
values of 1, 2, 5 and 10 years. The model was also tested for the 
sensitivity of results to the structural updates to the model. Finally, 
the contribution of each of the four individual behaviors to costs and 
QALYs was assessed. 
 
 
RESULTS 
 
Costing analysis results 
 
Costs for full implementation of the U@Uni2 intervention 
were estimated at £61,828 (£50,544 to £73,158, 95% 
confidence interval [CI]), of which £47,179 was due to 
previous spending on U@Uni1 and £14,649 was specific 
to U@Uni2. Staff cost was £27,444 in total, whilst non-
staff costs comprised £34,384. This is considerably 
cheaper than the cost estimated for full implementation of 
U@Uni1 (Kruger et al., 2014), which when inflated to 
2013 values came to £213,921. The reason for the large 
difference is due predominantly to the use of the 
LifeGuide software for U@Uni2 (Yang et al., 2009), which 
eliminated the need for costly development of a website 
from scratch. Given that there were 1,345 individuals in 
the intervention arm of the RCT, this works out as £45.97 
per person (£37.58 to £54.39, 95% CI). 
Roll-out costs for U@Uni2 were estimated at £15,701 
(£13,555 to £17,864, 95% CI), of which £9,792 was due 
to previous spending on U@Uni1 and £5,909 was 
specific to U@Uni2. The comparable inflated costs for 
U@Uni1 were £30,768. The U@Uni1 costs were larger 
due to website maintenance that the U@Uni1 site 
required. The mean number of UCAS acceptances per 
UK institution in 2013 was 1,506 (Universities and 
Colleges Admissions Service, 2013). Dividing U@Uni2 
roll-out costs by this figure results in a cost of £10.43 per 
person (£9.00 to £11.86, 95% CI).  
The costs of rolling out U@Uni2 over a five year period 
were estimated as £4,563 per year (£3,842-£5,292, 95% 
CI), of which £2,946 was due to annuitized setting up 
costs and £1,617 was yearly maintenance costs. This 
was equivalent to £3.03 per student (£2.55 to £3.51, 95% 
CI). Comparable inflated costs for U@Uni1 were £9,434 
(£8,530-£11,234, 95% CI), of which £6,069 was due to 
annuitized setting up costs and £3,365 was yearly 
maintenance costs. This worked out  as  £6.26  (£5.66  to  
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£7.46, 95% CI) per person. 
 
 
Within-trial cost-effectiveness analysis results 
 
The within-trial analysis found that the U@Uni2 
intervention cost an extra £35.30 (£30 to £40.51, 95% CI, 
based on 5000 bootstrap runs) per individual when 
compared with the control arm, considerably lower than 
the incremental costs generated in the intervention arm of 
the U@Uni1 trial (£326.37). The incremental cost was 
entirely due to the cost of the intervention, as healthcare 
utilization was reduced in the intervention arm of the trial, 
resulting in lower healthcare costs when compared with 
the control arm (-£10.67). Although, the intervention 
group used fewer healthcare resources during the 6-
month trial period, they also gained fewer QALYs than 
the control group (-0.0025 incremental QALYs), although 
this was not statistically significant (0.0001 to -0.0051, 
95% CI, based on 5000 bootstrap runs).  
The incremental cost-effectiveness ratio (ICER) was 
calculated at -£14,314 per QALY gained (at a threshold 
of £20,000 per QALY). INB was found to be -£84.63, 
indicating that the intervention is not cost-effective in the 
short-term, due to the negative estimated QALY gain. 
Uncertainty analysis determined that the probability the 
intervention would be cost-effective at this threshold is 
only 0.0004 (Figure 1). 
 
 
Long-term economic modelling results 
 
The long-term lifetime economic modelling results are 
presented in detail in Error! Reference source not 
found. and Figure 2. Both U@Uni1 and U@Uni2 produce 
small increases in life years and QALYs gained as 
compared to the control. However, U@Uni2 is slightly 
less effective than U@Uni1, producing only 0.00533 
incremental QALYs when compared with the 0.00767 
incremental QALYs produced by U@Uni1.  
Incremental costs for full implementation of U@Uni2 
when compared with control are £37.90, resulting in an 
ICER of £7,106, an INB of £69 and a probability cost-
effective of 76% (Tables 1 and Figure 2). In contrast, 
incremental costs for full implementation of U@Uni1 are 
£152.94. The intervention is marginally cost-effective with 
an ICER of £19,947, but there is a high level of 
uncertainty around this result as the probability cost-
effective is only 49%. Direct comparison indicates that 
the updated U@Uni2 intervention is more likely to be 
cost-effective than the original U@Uni1 intervention, with 
a probability of 75% and INB of £68 (Table 1). 
Roll-out of U@Uni2 costs only £2.86 per person, when 
compared with £9.26 for roll-out of U@Uni1. Both 
interventions are likely to be cost-effective in the roll-out 
scenario when compared with control to a similar extent 
(ICER = £1,207 for U@Uni1, probability cost-effective 
=93%; ICER = £536 for U@Uni2, probability cost-effective 
= 86%) (Table 1  and  Figure 2). Despite higher costs, the  
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Figure 1. Within-trial cost-effectiveness planes and cost-effectiveness acceptability curves for 
U@Uni2 as compared to do nothing control. The individual-level cost-effectiveness plane and cost-
effectiveness acceptability curve resulting from 5,000 bootstrap replicates in the within-trial cost-
effectiveness analysis. A) Cost-effectiveness plane showing the incremental costs and QALYs 
accumulated over the 6 month trial period for full development and implementation of U@Uni2 
compared to control. B) Cost-effectiveness acceptability curve showing the probability (out of 5,000 
bootstrap replicates) that full development and implementation of U@Uni2 is cost-effective 
compared to control for a range of willingness-to-pay thresholds. 
 
 
 
net benefit gained by U@Uni1 (£144) is slightly higher 
than for U@Uni2 (£104), due to its larger incremental 
QALY gain. However, there is a high level of uncertainty 
around   the   relative    cost-effectiveness    of    the   two 
interventions and they occupy similar distributions on the 
cost-effectiveness plane (Figure 2B). 
Rolling out either intervention over a five year period is 
estimated  to  be  cost  saving as compared to control, as  
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Table 1. The incremental long-term cost-effectiveness of U@Uni (per person). 
 
 
U@Uni1 vs 
Control 
U@Uni2 vs 
Control 
U@Uni1 vs 
U@Uni2 
Scenario 1: Full development and implementation of U@Uni1/U@Uni2 
Discounted life years 0.00070 0.00062 0.00008 
Discounted QALYs 0.00767 0.00533 0.00233 
Discounted costs £152.94 £37.90 £115.04 
ICER  £19.947 £7.106 £49.278 
INB** at threshold of £20,000 per QALY  £0.41 £69 -£68 
Probability cost-effective at willingness-to-pay threshold of £20,000 per QALY  48.7% 76.1% 24.1% 
    
Scenario 2: Roll-out of U@Uni1/U@Uni2 
Discounted life years 0.00070 0.00062 0.00008 
Discounted QALYs 0.00767 0.00533 0.00233 
Discounted costs £9.26 £2.86 £6.40 
ICER  £1,207 £536 £2,741 
INB** at threshold of £20,000 per QALY £145 £104 £40 
Probability cost-effective at willingness-to-pay threshold of £20,000 per QALY 92.7% 86.4% 65.9% 
    
Scenario 3: Roll-out of U@Uni2 over five years 
Discounted life years 0.00070 0.00062 0.00008 
Discounted QALYs 0.00767 0.00533 0.00233 
Discounted costs -£5.30 -£4.50 -£0.80 
ICER  -£692 -£844 -£344 
INB** at threshold of £20,000 per QALY £159 £111 £47 
Probability cost-effective at willingness-to-pay threshold of £20,000 per QALY 95.1% 88.2% 68.4% 
Probability cost-saving at willingness-to-pay threshold of £20,000 per QALY 67.7% 66.7% 53.5% 
 
*Any apparent discrepancies are due to rounding; **Incremental net monetary benefit = incremental QALYs x willingness-to-pay threshold – 
incremental costs. 
 
 
 
the reduction in healthcare cost outweighs the cost of the 
interventions. £5.30 is saved per person for U@Uni1 and 
£4.50 is saved per person for U@Uni2. Again, both 
interventions are highly likely to be cost-effective when 
compared with control (INB of U@Uni1 = £159, 
probability cost-effective = 95%; INB of U@Uni2 = £111, 
probability cost-effective = 88%), and are cost-effective 
as compared to the standard roll-out from a cost-
minimization perspective.  
 
 
Structural sensitivity analyses  
 
Sensitivity analyses suggest that the results are not 
sensitive to the removal of model updates, but they are 
sensitive to the method of imputation for missing data 
(Appendix Table 2). 
The cost-effectiveness of all scenarios is correlated 
with the duration of intervention effect (Table 2). For roll-
out, both interventions have almost 70% probability of 
being cost-effective even if the mean duration of 
intervention effect is only 1 year, and by 10 years, both 
interventions are cost saving. Rollout of both interventions 
over  5  years  is  highly likely  to  be  cost-effective  in  all 
situations, but only becomes cost-saving if duration of 
intervention effect lasts for about 2-3 years. 
The model allows assessment of the individual 
contribution of each health behaviour change to quality of 
life and mortality. Results show that the reduction in 
smoking accounts for almost 75% of the incremental life 
years gained with U@Uni1 and over 60% of the 
incremental life years gained with U@Uni2. An increase 
in physical activity accounts for a further 20% of 
incremental life years gained whilst the other two 
behaviours contribute only very slightly to mortality 
reductions. The utility effects of smoking are even more 
dramatic than the mortality effects, such that the entire 
QALY gain seen in both interventions is purely due to the 
effect of the interventions on smoking.  
 
 
Value of information 
 
Value of information analysis was performed for roll-out 
of the U@Uni2 intervention versus the control only. The 
overall value of information from EVPI analysis was found 
to be £6.54 per person for the roll-out of U@Uni2. The 
population  potentially  affected  by  the  decision was the  
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Figure 2. Cost-effectiveness planes and cost-effectiveness acceptability curves for long-term modelling of full implementation and roll-out of 
U@Uni1 and U@Uni2 interventions, compared to a do nothing control. A) Cost-effectiveness plane showing the per-person incremental discounted 
lifetime costs and incremental discounted lifetime QALYs for full implementation of U@Uni1 and U@Uni2 compared to a do nothing control. B) 
Cost-effectiveness plane showing the per-person incremental discounted lifetime costs and incremental discounted lifetime QALYs for roll-out of 
U@Uni1 and U@Uni2 compared to a do nothing control. C) Cost-effectiveness acceptability curve (CEAC) showing the probability (out of 30,000 
PSA runs) that full development of U@Uni2 compared with control is cost-effective at different willingness-to-pay thresholds. D) Cost-effectiveness 
acceptability curve (CEAC) showing the probability (out of 30,000 PSA runs) that roll-out of U@Uni2 compared with control is cost-effective at 
different willingness-to-pay thresholds. 
 
 
 
individuals starting university each year. In 2013, there 
were 495,560 UCAS acceptances in the UK (Universities 
and Colleges Admissions Service, 2013), meaning that it 
could be worth spending up to £3.24 million on further 
research that would enable an accurate decision to be 
made within a year. EVPPI analysis indicates that 
decision uncertainty is driven primarily by the parameters 
relating to the effects of the intervention on health 
behaviours, worth up to £3.79 per person or  £1.9  million 
in total (Table  3). The individual parameters that have by 
far the most influence are the rates of non-smokers 
taking up smoking in the U@Uni2 and control conditions, 
which are worth 31p and 21p per person, respectively.  
 
 
DISCUSSION 
 
The  U@Uni2  intervention  is  an  updated  version of the 
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Table 2. Comparison of incremental cost-effectiveness results over different durations of intervention effect. 
 
DURATION OF EFFECT 
U@Uni1 vs Control U@Uni2 vs Control 
QALYs Costs INB Prob. CE QALYs Costs INB Prob. CE 
Scenario 1: Full development and implementation of U@Uni1/U@Uni2 
1 yr 0.00185 £162.19 -£125.27 0.1% 0.00138 £43.76 -£16.22 34% 
2 yrs 0.00367 £159.09 -£85.72 6.6% 0.00266 £41.69 £11.58 57.8% 
5 yrs 0.00923 £150.16 £34.44 62.5% 0.00645 £36.29 £92.67 79.9% 
10 yrs 0.01871 £135.72 £238.54 87.6% 0.01266 £28.68 £224.45 87.5% 
         
Scenario 2: Roll-out of U@Uni1/U@Uni2 
1 yr 0.00185 £18.69 £18.23 68.7% 0.00138 £8.69 £18.85 69.6% 
2 yrs 0.00367 £15.59 £57.78 83.7% 0.00266 £6.62 £46.65 80.5% 
5 yrs 0.00923 £6.67 £177.94 94.4% 0.00645 £1.22 £127.74 87.7% 
10 yrs 0.01871 -£7.78 £382.04 97.3% 0.01266 -£6.39 £259.52 90.7% 
         
Scenario 3: Roll-out of U@Uni2 over 5 years 
1 yr 0.00185 £4.18 £32.74 80.9% 0.00138 £1.31 £26.23 76.0% 
2 yrs 0.00367 £1.07 £72.29 91.0% 0.00266 -£0.75 £54.03 83.7% 
5 yrs 0.00923 -£7.85 £192.45 96.2% 0.00645 -£6.15 £135.11 89.1% 
10 yrs 0.01871 -£22.12 £396.38 97.8% 0.01266 -£13.76 £266.90 91.5% 
 
QALY, Quality Adjusted Life Year; INB, Incremental Net Monetary Benefit; Prob. CE Probability Cost-Effective. 
 
 
 
Table 3. EVPPI values for key single parameters and parameter combinations implicated in decision uncertainty when comparing 
U@Uni2 roll-out with a do nothing control. 
 
Parameters 
Roll-out of U@Uni2 vs Control 
Per Person 
UCAS population mean 
Mean St. error 
Probability non-smokers start smoking (do nothing) £0.21 £0.02 £105,100 
Probability non-smokers start smoking (U@Uni2) £0.31 £0.02 £153,800 
Physical activity: U@Uni2 intervention coefficient £0.00 £0.00 £2,392 
All intervention effects total £3.79 £0.15 £1,878,200 
Intervention effects – all smoking parameters £2.03 £0.15 £1,006,000 
Intervention effects – all fruit/veg parameters £0.00 £0.00 £0 
Intervention effects – all physical activity parameters £0.01 £0.01 £4,956 
Intervention effects – all alcohol parameters £0.00 £0.00 £0 
Utility coefficients (all) £0.44 £0.28 £218,000 
 
 
 
U@Uni theory-based online health behaviour intervention 
for students as they start university (Cameron et al., 
2015; Epton et al., 2014). This analysis shows that the 
U@Uni2 intervention is considerably cheaper to 
implement than U@Uni1. However, lifetime modelling 
indicates that U@Uni2 is likely to be less effective than 
U@Uni1, producing both fewer life years and fewer 
QALYs. Roll-out of U@Uni2 is highly likely to be more 
cost-effective than doing nothing, but is not likely to be 
more cost-effective than roll-out of U@Uni1. 
The LifeGuide software was more user-friendly than the 
U@Uni1 website, and this together with some changes to 
trial design resulted in increased levels of recruitment and 
engagement with the intervention (Cameron et al., 2015). 
Despite these changes, the U@Uni2 intervention did not 
show a significant improvement in any of the four 
behaviours and the U@Uni2 trial itself was not found to 
be cost-effective due to a small reduction in health-
related quality-of-life. QALY loss during the trial is likely to 
be due to stochastic sample variability and low sensitivity 
of the EQ-5D to measuring subtle changes in quality of 
life at the top of the scale (Brazier et al., 2007). 
Improvements in smoking behaviour appear to account 
for  the  vast  majority  of life-years and QALYs gained for  
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both interventions. This is driven by the large effects 
smoking has on both quality of life and mortality 
compared with the other behaviours (Kruger et al., 2014; 
Kvaavik et al., 2010). A recent review of the economic 
impacts of smoking suggests that the direct costs of 
smoking may use 5% of the annual NHS budget, and far 
outweigh any economic benefits such as increased tax 
intake (Ekpu and Brown 2015). This suggests that 
specifically targeting smoking may not only be the best 
way to improve the health of young people, but will have 
positive economic consequences in the long term. In line 
with this, smoking cessation programmes aimed at young 
people have been found to be highly cost-effective in 
other economic analyses (Dino et al., 2008; Hollingworth 
et al., 2012). 
A series of sensitivity analyses were carried out to test 
assumptions of model structure and methodology. 
Sensitivity analyses around the duration of intervention 
effect produced the largest changes in cost-effectiveness. 
Very little work has been done to investigate the likely 
duration of effect of online health interventions; this would 
be a useful area for further research. EVPPI analysis 
indicates that the highest level of decision uncertainty is 
around the effect of the intervention on health behaviours, 
particularly smoking. As intervention effectiveness is key 
to deciding whether to fund U@Uni2, decision makers 
may wish to invest in gathering more information to 
inform these parameters. 
Taken together, the results of the two U@Uni trials 
suggest that online interventions can have a positive 
effect on health behaviours in new university students. 
These effects may be very small, but over a lifetime can 
result in significant health gains that are extremely cost-
effective to implement. Similar small but positive effects 
have been found recently in other trials of online 
interventions aiming to reduce unhealthy behaviours in 
students (Kattelmann et al.,  2014; Kypri et al., 2014). 
However, the U@Uni interventions remain unique 
amongst similar online health behaviour interventions in 
their demonstration of cost-effectiveness in addition to 
efficacy.  
This study was performed from the perspective of the 
UK Department of Health; however, it is unclear whether 
they would be willing to fund such an intervention. Public 
health funding is concerned both with maximizing 
efficiency and reducing inequity (National Institute for 
Health and Clinical Excellence, 2012). University students 
are disproportionately from more privileged backgrounds 
(Universities and Colleges Admissions Service, 2014), 
and individuals with a degree have better health outcomes 
(Higher Education Funding Council for England, 2001) 
meaning that funding the U@Uni2 intervention could act 
to increase health inequalities. However, given the 
commitment of universities in England to the “Healthy 
Universities Scheme” to improve student health and well-
being (UK National Healthy Universities Network, 2015), 
and the relatively low  costs  involved,  larger  universities  
 
 
 
 
may themselves wish to consider funding a U@Uni2 type 
intervention as part of their student health and well-being 
programme.   
 
 
Conclusions and recommendations 
 
This study estimates the costs and cost-effectiveness of 
U@Uni2, an updated version of the U@Uni trial of an 
online intervention targeting multiple health behaviours in 
new university students. The study shows that U@Uni 
type interventions are cost-effective to roll-out and 
suggests that universities committed to student health 
consider such an intervention given the low costs 
involved. Most of the decision uncertainty is associated 
with the effect of the intervention on health behaviour 
change, suggesting that further research should focus on 
this area. Given that intervention efficacy is almost 
entirely dependent on the smoking effect, targeting 
smoking is a priority for improving healthy behaviours in 
young people. 
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Appendix 
 
A full list of all the parameters used in the model and their values and distributions. 
 
Table 1. Model input parameters. 
 
Parameter Distribution Parameters* Source 
Individual baseline characteristics 
Age (years) Individual-
level data 
Mean = 18.81 
SD = 2.36 
U@Uni2 RCT 
Gender Individual-
level data 
44.8% Male 
55.2% Female 
Fruit and vegetables (portions per day) Individual-
level data 
Mean = 4.49 
SD = 2.27 
Alcohol (units per week) Individual-
level data 
Mean = 6.87 
SD = 9.51 
Physical activity (minutes per week) Individual-
level data 
Mean = 814.16 
SD = 765.95 
Smoking status Individual-
level data 
2.9% Smoker 
97.1% Non-smoker 
Costs 
U@Uni1 cost (full development) Lognormal Mean ln(cost) = 
12.30663 
SD ln(cost) = 0.05185 
Costing analysis 
U@Uni1 cost (roll-out) Lognormal Mean ln(cost) = 
10.36116 
SD ln(cost) = 0.06628 
Costing analysis 
U@Uni2 cost (full development) Lognormal Mean ln(cost) = 
11.01548 
SD ln(cost) = 0.09433 
Costing analysis 
U@Uni2 cost (roll-out) Lognormal Mean ln(cost) = 
9.65251 
SD ln(cost) = 0.07043 
Costing analysis 
U@Uni2 cost (roll-out over 5 years) Lognormal Mean ln(cost) = 
8.41381 
SD ln(cost) = 0.08173 
Costing analysis 
Intervention effect regression coefficients 
β0 Fruit and vegetables: constant Multivariate 
normal 
(see 
Additional 
file 1 for 
covariance 
matrix) 
Mean = 0.7696 U@Uni1 & 
U@Uni2 RCTs β1 Fruit and vegetables: baseline behaviour 
coefficient  
Mean = 0.4583 
β2 Fruit and vegetables: age coefficient Mean = 0.0722 
β3 Fruit and vegetables: gender coefficient (1 = 
male; 0 = female) 
Mean = -0.4053 
β4 Fruit and vegetables: U@Uni1 intervention 
coefficient (i.e. mean effect of U@Uni1 on 
portions of fruit and vegetables per day 
compared to control) 
Mean = -0.05387 
Β5 Fruit and vegetables: U@Uni2 intervention 
coefficient (i.e. mean effect of U@Uni2 on 
portions of fruit and vegetables per day 
compared to control) 
Mean = 0.1714 
β0 Alcohol: constant Multivariate 
normal (see 
Additional 
file 1 for 
covariance 
matrix) 
Mean = 14.720 U@Uni1 & 
U@Uni2 RCTs β1 Alcohol: baseline behaviour coefficient Mean = 0.6408 
β2 Alcohol: age coefficient Mean = -0.5077 
β3 Alcohol: gender coefficient  (1 = male; 0 = 
female) 
Mean = 2.8588 
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β4 Alcohol: U@Uni1 intervention coefficient (i.e. 
mean effect of U@Uni1 on units of alcohol per 
week compared to control) 
 Mean = -0.20932  
Β5 Alcohol: U@Uni2 intervention coefficient (i.e. 
mean effect of U@Uni2 on units of alcohol per 
week compared to control) 
Mean = -0.5032 
β0 Physical activity: constant Multivariate 
normal (see 
Additional 
file 1 for 
covariance 
matrix) 
Mean = 563.26 U@Uni1 & 
U@Uni2 RCTs β1Physical activity: baseline behaviour 
coefficient 
Mean = 0.2068 
β2 Physical activity: age coefficient Mean = 2.1423 
β3 Physical activity: gender coefficient  (1 = 
male) 
Mean = 77.835 
β4 Physical activity: U@Uni1 intervention 
coefficient (i.e. mean effect of U@Uni1 on 
minutes of physical activity per week compared 
to control) 
Mean = 25.93877 
Β5 Physical activity: U@Uni2 intervention 
coefficient (i.e. mean effect of U@Uni2 on 
minutes of physical activity per week compared 
to control) 
Mean = 17.759 
 
Probability smokers quit smoking (U@Uni1) Beta α = 5.4 
β = 13.6 
U@Uni1 RCT 
Probability non-smokers start smoking 
(U@Uni1) 
α = 22.83  
β = 547.17 
Probability smokers quit smoking (U@Uni2) Beta α = 3.72 
β = 15.28  
U@Uni2 RCT 
Probability non-smokers start smoking 
(U@Uni2) 
α = 27.47 
β = 542.53 
Probability smokers quit smoking (do nothing) Beta α = 3.81 
β = 17.19 
Probability non-smokers start smoking (do 
nothing) 
α = 50.29 
β = 602.71 
Lag effects (years until full effect of behaviour change on mortality risk) 
Fruit and vegetables lag Lognormal Mean = 2.7438 
SD = 0.1247 
Expert elicitation 
Alcohol lag Gamma α = 1.3541 
β = 0.6537 
Physical activity lag Normal Mean = 5.5000 
SD = 1.4642 
Smoking lag Normal Mean = 5.5000 
SD = 1.1110 
Distribution of individual-level duration of U@Uni behavioural effect (years)** 
Mean duration Beta α = 1.8179 
β = 0.1304 
Scale = 4.5000 
Expert elicitation 
Standard deviation of duration α = 2.9109 
β = 0.2691 
Scale = 3.3800 
Hazard ratios for effect of health behaviours on mortality risk 
Fruit and vegetable consumption Lognormal Mean = 0.0953 
SD = 0.0673 
Kvaavik et al. 
(2010) (16) 
Alcohol consumption Mean = 0.1655 
SD = 0.0840 
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Physical activity  Mean = 0.3577 
SD = 0.0641 
 
Smoking status Mean = 0.3577 
SD = 0.0873 
Utility ordinary least squares regression model coefficients 
β0 Constant Multivariate 
normal (see 
Additional 
file 1 for 
covariance 
matrix) 
Mean = 0.9490 Analysis of Health 
Survey for England 
2008 (17) 
β1 Age coefficient Mean = -0.0038 
β2 Gender (1 = male; 0 = female) coefficient Mean = 0.0142 
β3 Fruit and vegetables (portions per day) 
coefficient 
Mean = 0.0207 
β4 Alcohol (units per week) coefficient Mean = 0.0016 
β5 Smoke (smoker = 1; non-smoker = 2) 
coefficient 
Mean = -0.0541 
β6 Physical activity (minutes per week) 
coefficient 
Mean = 0.0002 
β7 Age
2
 Mean = -4.31 x 10
-06
 
β8 Fruit and vegetables
2
 Mean = -0.0033 
β9 Fruit and vegetables
3
 Mean = 0.0001 
β10 Alcohol
2
 Mean = -2.77 x 10
-05
 
β11 Alcohol
3
 Mean = 6.45 x 10
-08
 
β12 Physical activity
2
 Mean = -2.59 x 10
-07
 
β13 Physical activity
3
 Mean = 4.88 x 10
-11
 
β14 Age*Fruit and vegetables interaction Mean = 4.94 x 10
-05
 
β15 Age*Alcohol interaction Mean = 1.61 x 10
-05
 
β16 Age*Physical activity Mean = 2.47 x 10
-06
 
Age and sex dependent smoking quit rates 
Men aged 16-19 Multivariate 
normal (see 
Additional 
file 1 for 
covariance 
matrix) 
Mean = 0.0469 Kemm et al. (2003) 
(11) 
Men aged 20-24 Mean = 0.0219 
Men aged 25-34 Mean = 0.0193 
Men aged 35-44 Mean = 0.0186 
Men aged 45-54 Mean = 0.0354 
Men aged 55-64 Mean = 0.044 
Men aged 65-74 Mean = 0.0618  
Men aged 75+ Mean = 0.0484 
Women aged 16-19 Mean = 0.0551 
Women aged 20-24 Mean = 0.0178 
Women aged 25-34 Mean = 0.0288 
Women aged 35-44 Mean = 0.0255 
Women aged 45-54 Mean = 0.0239 
Women aged 55-64 Mean = 0.0563 
Women aged 65-74 Mean = 0.0581 
Women aged 75+ Mean = 0.0966 
Healthcare utilisation probit model regression coefficients 
β0 Constant Multivariate 
normal (see 
Additional 
file 1 for 
covariance 
matrix) 
Mean = 2.519442 Analysis of 
Yorkshire Health 
Study (12) 
β1 Age coefficient Mean = -0.03155 
β2 EQ-5D coefficient Mean = -0.81372 
β3 Age
2
 Mean = 0.000221 
β4 EQ-5D
2
 Mean = -1.27013 
β5 Oldage (>=65 = 1; <65 = 0) Mean = 0.174598 
β6 Age*EQ-5D interaction Mean = 0.01363 
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β7 Uni education (uni = 1, no uni = 0) coefficient  Mean = 0.089921  
β8 Gender (1 = male; 0 = female) coefficient Mean = -0.17944 
β9 Smoke (smoker = 1; non-smoker = 2) 
coefficient 
Mean = -0.09011 
Healthcare utilisation generalised linear model regression coefficients 
β0 Constant Multivariate 
normal 
Mean = -1.78686 Analysis of 
Yorkshire Health 
Study (12) 
Β1 EQ-5D coefficient Mean = 7.478248 
 
*SD = standard deviation. **The sampled mean and standard deviation from the beta distributions are then converted to log (mean) 
and log (standard deviation) and used as parameters for the lognormal distribution for individual-level durations of response. 
 
 
Table 2. Comparison of incremental cost-effectiveness results using different imputation methods. 
 
IMPUTATION METHOD 
U@Uni1 vs Control U@Uni2 vs Control 
QALYs Costs INB Prob. CE QALYs Costs INB Prob. CE 
Scenario 1: Full development and implementation of U@Uni1/U@Uni2 
MICE (default) 0.00767 £152.94 £0.41 48.7% 0.00533 £37.90 £68.76 76.1% 
LOCF 0.00334 £165.11 -£98.41 17.9% 0.00418 £36.52 £47.07 68.1% 
Complete Case 0.00625 £154.93 -£29.91 37.5% 0.00523 £37.37 £67.19 73.3% 
 
Scenario 2: Roll-out of U@Uni1/U@Uni2 
MICE (default) 0.00767 £9.26 £144.09 92.7% 0.00533 £2.86 £103.80 86.4% 
LOCF 0.00334 £21.40 £45.31 67.1% 0.00418 £1.54 £82.06 81.0% 
Complete Case 0.00625 £11.37 £113.66 86.7% 0.00523 £2.31 £102.25 84.4% 
 
Scenario 3: Roll-out of U@Uni2 over 5 years 
MICE (default) 0.00767 -£5.30 £158.65 95.1% 0.00533 -£4.50 £111.16 88.2% 
LOCF 0.00334 £6.79 £59.91 72.2% 0.00418 -£5.84 £89.43 83.7% 
Complete Case 0.00625 -£3.23 £128.26 89.7% 0.00523 -£5.06 £109.63 86.4% 
 
MICE Multiple Imputation using Chained Equations; LOCF Last Observation Carried Forward; QALY Quality Adjusted Life Year; INB 
Incremental Net Monetary Benefit; Prob. CE Probability Cost-Effective. 
 
 
 
 
 
